Dawn C. Maroney - Mar 13, 2025 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Role
President
Signature
/s/ Christopher J. Joyce, as Attorney-in-Fact, for Dawn C. Maroney
Stock symbol
ALHC
Transactions as of
Mar 13, 2025
Transactions value $
-$479,688
Form type
4
Date filed
3/17/2025, 05:57 PM
Previous filing
Mar 13, 2025
Next filing
Mar 19, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALHC Common Stock Award $0 +171K +7.51% $0.00 2.45M Mar 13, 2025 Direct F1
transaction ALHC Common Stock Sale -$480K -30K -1.23% $15.99 2.42M Mar 17, 2025 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents (i) 119,355 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; (ii) 19,355 fully vested shares of Common Stock granted in lieu of cash settlement of the annual incentive award earned by the reporting person for the 2024 fiscal year; and (iii) 32,258 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors.
F2 Date of Rule 10b5-1 plan adoption: 03/13/2024
F3 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.53 to $16.20. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.